Primary biliary cholangitis
Not yet recruitingSaroglitazar hemimagnesium normalizes alkaline phosphatase in primary biliary cholangitis patients with incomplete response or intolerance to ursodeoxycholic acid
Saroglitazar hemimagnesium normalizes alkaline phosphatase in primary biliary cholangitis patients with incomplete response or intolerance to ursodeoxycholic acid
- Disease:Primary biliary cholangitis
- Substances:Saroglitazar hemimagnesium
Spain- Participants:18–64 years · 65+ years
- Substances:Saroglitazar hemimagnesium
- Sponsor:Zydus Therapeutics Inc.










